JPS6445312A - Sedimentation inhibitor-free stable scralfate suspension-state drug composition - Google Patents

Sedimentation inhibitor-free stable scralfate suspension-state drug composition

Info

Publication number
JPS6445312A
JPS6445312A JP63091854A JP9185488A JPS6445312A JP S6445312 A JPS6445312 A JP S6445312A JP 63091854 A JP63091854 A JP 63091854A JP 9185488 A JP9185488 A JP 9185488A JP S6445312 A JPS6445312 A JP S6445312A
Authority
JP
Japan
Prior art keywords
sucralfate
solution
gel
medicine composition
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63091854A
Other languages
English (en)
Other versions
JPH0576927B2 (ja
Inventor
Zaniyoori Jiyanni
Konte Yuu
Koronbo Pii
Kiyarameera Shii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIZAFUARUMA SpA
Original Assignee
RIZAFUARUMA SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIZAFUARUMA SpA filed Critical RIZAFUARUMA SpA
Publication of JPS6445312A publication Critical patent/JPS6445312A/ja
Publication of JPH0576927B2 publication Critical patent/JPH0576927B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Stereo-Broadcasting Methods (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Lift-Guide Devices, And Elevator Ropes And Cables (AREA)
  • Saccharide Compounds (AREA)
JP63091854A 1987-04-15 1988-04-15 Sedimentation inhibitor-free stable scralfate suspension-state drug composition Granted JPS6445312A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20129/87A IT1203901B (it) 1987-04-15 1987-04-15 Composizioni farmaceutiche sotto forma di sospensioni stabili di sucralfato esenti da agenti sospendenti

Publications (2)

Publication Number Publication Date
JPS6445312A true JPS6445312A (en) 1989-02-17
JPH0576927B2 JPH0576927B2 (ja) 1993-10-25

Family

ID=11164041

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63091854A Granted JPS6445312A (en) 1987-04-15 1988-04-15 Sedimentation inhibitor-free stable scralfate suspension-state drug composition

Country Status (20)

Country Link
US (1) US5321013A (ja)
EP (1) EP0286978B1 (ja)
JP (1) JPS6445312A (ja)
KR (1) KR930006037B1 (ja)
CN (1) CN1021629C (ja)
AT (1) ATE58144T1 (ja)
AU (1) AU623853B2 (ja)
CA (1) CA1306945C (ja)
DE (1) DE3860967D1 (ja)
DK (1) DK175683B1 (ja)
ES (1) ES2021781B3 (ja)
FI (1) FI88257C (ja)
GR (1) GR3002515T3 (ja)
IE (1) IE61339B1 (ja)
IN (1) IN169494B (ja)
IT (1) IT1203901B (ja)
MX (1) MX11135A (ja)
NO (1) NO174656C (ja)
NZ (1) NZ224253A (ja)
ZA (1) ZA882476B (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004030A1 (en) * 1990-08-31 1992-03-19 Chugai Seiyaku Kabushiki Kaisha Stock solution of sucralfate suspended in water and production thereof
WO1995028938A1 (fr) * 1994-04-26 1995-11-02 Chugai Seiyaku Kabushiki Kaisha Preparation de sucralfate granulee et fondue et son procede de production
JP2016145187A (ja) * 2015-01-28 2016-08-12 ライオン株式会社 ゲル組成物及びその製造方法
JP2016222545A (ja) * 2015-05-27 2016-12-28 ライオン株式会社 スクラルファート含有液状組成物
CN109431972A (zh) * 2018-11-20 2019-03-08 昆明积大制药股份有限公司 一种粒径为100nm—500nm的硫糖铝凝胶的成胶方法

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2735559B2 (ja) * 1988-03-02 1998-04-02 中外製薬株式会社 懸濁液
IT1230157B (it) * 1989-06-16 1991-10-14 Lisapharma Spa Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica
FR2657010B1 (fr) * 1990-01-12 1992-05-15 Pf Medicament Composition pharmaceutique sous forme de suspension aqueuse stable a base de sucrafalte et d'une substance anti-acide ainsi que son procede de preparation.
DK86492D0 (da) * 1992-06-30 1992-06-30 Bukh Meditec Laegemiddel
IT1264546B1 (it) * 1993-07-30 1996-10-02 Lisapharma Spa Composizione farmaceutica ad attivita' antiacida in forma di sospensione a base di gel di sucralfato
IT1274735B (it) * 1994-08-25 1997-07-24 Enosys S P A Farmaco e vettore per le patologie infiammatorie ed erosive del tratto gastrointestinale a base di sucralfato allo stato di gel secco
IT1284030B1 (it) * 1996-06-18 1998-05-08 Solchem Italiana Spa Metodo per la produzione di sospensioni acquose stabili, utili nelle composizioni farmaceutiche
IT1301969B1 (it) * 1998-07-30 2000-07-20 Lisapharma Spa Sucralfato gel secco granulare e poroso procedimento per la suapreparazione, e composizioni farmaceutiche solide che lo contengono
US6391860B1 (en) * 1999-09-09 2002-05-21 Mcgrath Patrick D. Method for preparation and use of paste formed by controlled reaction of sucralfate with hydrochloric acid
CN100425244C (zh) * 2004-04-14 2008-10-15 中国人民解放军总医院 注射用硫酸铝，用于治疗膀胱肿瘤的注射用硫酸铝注射液
WO2010033408A1 (en) * 2008-09-17 2010-03-25 Mcgrath Patrick D Antimicrobial sucralfate paste methods and compositions
US10716802B2 (en) 2013-03-15 2020-07-21 The Brigham And Women's Hospital, Inc. Compounds to modulate intestinal absorption of nutrients
GR1008308B (el) 2013-05-31 2014-10-02 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα
US10973846B2 (en) 2015-09-24 2021-04-13 The Brigham And Women's Hospital, Inc. Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512344A1 (fr) * 1981-09-08 1983-03-11 Af Aplicaciones Far Lab Procede de fabrication d'une suspension stable d'hydroxyde d'alumine et/ou d'hydroxyde de magnesie comme agent actif des antacida
JPS5978116A (ja) * 1982-10-27 1984-05-04 Chugai Pharmaceut Co Ltd スクラルフェ−ト製剤
DE3429263A1 (de) * 1984-08-08 1986-02-20 Gödecke AG, 1000 Berlin Verfahren zur stabilisierung filtrierbarer antacida mit hexitolen
DE3430809A1 (de) * 1984-08-22 1986-03-06 Merck Patent Gmbh, 6100 Darmstadt Sucralfat-suspension

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARZNEIMITTEL-FORSCHUNG DRUG RESEARCH=1979 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004030A1 (en) * 1990-08-31 1992-03-19 Chugai Seiyaku Kabushiki Kaisha Stock solution of sucralfate suspended in water and production thereof
WO1995028938A1 (fr) * 1994-04-26 1995-11-02 Chugai Seiyaku Kabushiki Kaisha Preparation de sucralfate granulee et fondue et son procede de production
JP2016145187A (ja) * 2015-01-28 2016-08-12 ライオン株式会社 ゲル組成物及びその製造方法
JP2016222545A (ja) * 2015-05-27 2016-12-28 ライオン株式会社 スクラルファート含有液状組成物
CN109431972A (zh) * 2018-11-20 2019-03-08 昆明积大制药股份有限公司 一种粒径为100nm—500nm的硫糖铝凝胶的成胶方法
CN109431972B (zh) * 2018-11-20 2022-02-22 昆明积大制药股份有限公司 一种粒径为100nm—500nm的硫糖铝凝胶的成胶方法

Also Published As

Publication number Publication date
NZ224253A (en) 1991-03-26
FI88257B (fi) 1993-01-15
ATE58144T1 (de) 1990-11-15
JPH0576927B2 (ja) 1993-10-25
IT1203901B (it) 1989-02-23
AU623853B2 (en) 1992-05-28
NO881625D0 (no) 1988-04-14
DK198488A (da) 1988-10-17
CA1306945C (en) 1992-09-01
AU1464388A (en) 1988-10-20
FI881769A (fi) 1988-10-16
IT8720129A0 (it) 1987-04-15
CN88102143A (zh) 1988-12-28
NO174656B (no) 1994-03-07
EP0286978B1 (en) 1990-11-07
ES2021781B3 (es) 1991-11-16
CN1021629C (zh) 1993-07-21
EP0286978A1 (en) 1988-10-19
IN169494B (ja) 1991-10-26
MX11135A (es) 1993-12-01
ZA882476B (en) 1988-09-29
IE61339B1 (en) 1994-11-02
NO881625L (no) 1988-10-17
DK198488D0 (da) 1988-04-12
GR3002515T3 (en) 1993-01-25
DE3860967D1 (de) 1990-12-13
FI88257C (fi) 1993-04-26
US5321013A (en) 1994-06-14
IE881038L (en) 1988-10-15
KR880012211A (ko) 1988-11-26
FI881769A0 (fi) 1988-04-15
KR930006037B1 (ko) 1993-07-03
DK175683B1 (da) 2005-01-17
NO174656C (no) 1994-06-15

Similar Documents

Publication Publication Date Title
JPS6445312A (en) Sedimentation inhibitor-free stable scralfate suspension-state drug composition
JP3403496B2 (ja) 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤
DE1916535C3 (de) Komplexe aus wasserlöslichen Salzen von sulfatierten Polysacchariden und basischen Aluminiumsalzen und Verfahren zu deren Herstellung
CA2071215A1 (en) Method and composition for treating inflammatory bowel disorders
PT91852A (pt) Processo para a preparacao de produtos contendo psyllium
TW197423B (ja)
FR2554814B1 (fr) Oxazolidines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement de l'obesite et du diabete
ATE171952T1 (de) Parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
KR970705988A (ko) 연골 조직의 이상에 기인하는 질환의 예방 또는 치료제(Preventive or remedy for diseases caused by abnormalities in cartilage tissues)
EP0395757B1 (en) Process for extracting physiologically active substance from pine seed shells and antiinfectant prepared mainly from the extract
DE3876817T2 (de) Anwendung des humanblut-koagulationsfaktors-xiii zur behandlung von colitis gravis.
RU93052161A (ru) Лекарственные средства, содержащие производные имидазол-1-ила
DE854245C (de) Verfahren zur Herstellung von Mitteln zur Inaktivierung proteolytischer Enzyme im Verdauungstraktus
BE904846A (fr) Steroides 11beta-substitues utiles notamment dans le traitement des tumeurs hormono-dependantes et procede pour la fabrication.
DE3714159A1 (de) Sucralfat-zubereitung und verfahren zu ihrer herstellung
JPS58152821A (ja) 配合医薬品
DE2220504A1 (de) Verfahren zur herstellung von arzneipraeparaten mit beschleunigter loeslichkeit
KR920017653A (ko) 플루나리진을 함유하는 항종양제 조성물
JPH0368010B2 (ja)
US3122578A (en) Complexes of tetracycline antibiotics and preparation of same
Lavrenova et al. Comparative evaluation of the effect of plant polysaccharides on the inflammatory process and regeneration in chronic stomach ulcer
Bauer et al. Investigations of trace metal content of normal and diseased nails.
Fantus Peroral administration of colloidal contrast medium in cholecystography
JPS5942318A (ja) 製薬組成物、その製造法及び応用
JPH0351688B2 (ja)

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees